Gilead nears up to $2bn deal for autoimmune biotech Ouro Medicines
Home - Financial Times [Unofficial]
March 23, 2026
California-based drugmaker takes advantage of surging share price to strike takeovers after a quiet couple of years
Discussion in the ATmosphere